Skip to main content
. 2012 Jun 28;2012:1007.
Ref (type) Population Outcome, Interventions Results and statistical analysis Effect size Favours
Adverse effects

Systematic review
827 people
5 RCTs in this analysis
Blood problems
with clozapine
with haloperidol/chlorpromazine
Absolute results not reported

RR 1.90
95% CI 0.97 to 3.71
Not significant

Systematic review
827 people
5 RCTs in this analysis
Drowsiness
with clozapine
with haloperidol/chlorpromazine
Absolute results not reported

RR 1.22
95% CI 1.11 to 1.34
Small effect size first-generation antipsychotic drugs

Systematic review
827 people
5 RCTs in this analysis
Too much salivation
with clozapine
with haloperidol/chlorpromazine
Absolute results not reported

RR 2.01
95% CI 1.74 to 2.32
Moderate effect size first-generation antipsychotic drugs

Systematic review
383 people
3 RCTs in this analysis
Too little salivation
with clozapine
with haloperidol/chlorpromazine
Absolute results not reported

RR 0.27
95% CI 0.16 to 0.45
Moderate effect size clozapine

Systematic review
484 people
3 RCTs in this analysis
Weight gain
with clozapine
with haloperidol/chlorpromazine
Absolute results not reported

RR 1.33
95% CI 1.11 to 1.59
Small effect size first-generation antipsychotic drugs

Systematic review
521 people
4 RCTs in this analysis
Movement disorder
with clozapine
with haloperidol/chlorpromazine
Absolute results not reported

RR 0.77
95% CI 0.67 to 0.90
Small effect size clozapine